Adaptive Biotechnologies Corp. (ADPT)
14.86
-0.09
(-0.60%)
USD |
NASDAQ |
Dec 09, 16:00
14.87
+0.01
(+0.07%)
After-Hours: 20:00
Adaptive Biotechnologies Shareholders Equity (Quarterly): 204.44M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Akero Therapeutics, Inc. | 957.64M |
| Ionis Pharmaceuticals, Inc. | 617.97M |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Vertex Pharmaceuticals, Inc. | 17.32B |
| Ultragenyx Pharmaceutical, Inc. | 9.159M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 490.61M |
| Total Liabilities (Quarterly) | 286.36M |
| Debt to Equity Ratio | 1.045 |
| Current Ratio | 3.376 |
| Net Debt Paydown Yield | 0.11% |